Validation and Implementation of 3T MRI Research Protocols
Launched by INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, FRANCE · Apr 29, 2021
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving how Magnetic Resonance Imaging (MRI) is conducted in research. Specifically, it's using a special MRI machine located at a research center to test and enhance the quality of MRI images. By developing and validating different MRI techniques, the goal is to create clearer images of the human brain and better understand various brain-related conditions. This research is important because high-quality images are crucial for accurate diagnoses and research outcomes.
To participate in this study, you need to be at least 18 years old, able to lie still for about 1.5 hours, and understand provided instructions. You also need to give written consent to take part. Unfortunately, individuals with certain psychiatric disorders, cognitive issues, or specific medical conditions that prevent MRI use cannot participate. If you join the trial, you can expect to help advance MRI technology, which could lead to better brain imaging techniques for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female, 18 years of age or older
- • Ability to cooperate and remain motionless for up to 1 hour (and lying down for 1.5 hours)
- • Ability to understand the instructions given
- • Subject who has given written and informed consent prior to any examination required by the research)
- • Subject affiliated to a social security system or benefiting from an equivalent system
- Exclusion Criteria:
- • Persons deprived of liberty by judicial or administrative decision
- • Psychiatric disorders, disorders of cognitive functions, not allowing the realization of the MRI
- • Protected adults (subject to a measure of legal protection) or unable to express their consent
- • Subject with Contraindications to MRI
About Institut National De La Santé Et De La Recherche Médicale, France
The Institut National de la Santé et de la Recherche Médicale (INSERM) is France's key public research organization dedicated to advancing knowledge in health and biomedical sciences. Established to foster innovation and improve public health outcomes, INSERM conducts a wide range of clinical trials and research initiatives aimed at translating scientific discoveries into effective medical treatments and interventions. With a focus on collaboration among researchers, healthcare professionals, and industry partners, INSERM plays a pivotal role in shaping health policies and enhancing the quality of care in France and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Patients applied
Trial Officials
Pierre PAYOUX, Pr
Principal Investigator
Inserm: UMR 1214 ToNIC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials